George Washington University Medical Center — Washington D.C., District of Columbia

Public research footprint of George Washington University Medical Center, compiled from the ClinicalTrials.gov public registry.

114

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Stage IIIB Lung Cancer AJCC v8 · Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 · Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma · Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Recently updated registry entries

NCT05987241 — Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of… (Recruiting)
NCT06096844 — Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With… (Recruiting)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at George Washington University Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.